Compounds > 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and lorazepam

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with lorazepam in 1 studies

Compound Research Comparison

Studies
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Trials
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Recent Studies (post-2010)
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Studies
(lorazepam)		Trials
(lorazepam)		Recent Studies (post-2010) (lorazepam)
33040333,078862625

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, GM; Baldwin, RM; Fujita, M; Innis, RB; Jatlow, PA; Seibyl, JP; Varrone, A; Verhoeff, NP; Zoghbi, SS1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and lorazepam

ArticleYear
Imaging extrastriatal dopamine D(2) receptor occupancy by endogenous dopamine in healthy humans.
    European journal of pharmacology, 2000, Jan-10, Volume: 387, Issue:2

    Topics: Adult; alpha-Methyltyrosine; Benzamides; Brain Chemistry; Dopamine; Female; Homovanillic Acid; Humans; Iodine Radioisotopes; Lorazepam; Male; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

2000